| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |